TY - JOUR
T1 - Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer
AU - Liu, C. Y.
AU - Wang, C. H.
AU - Chen, T. C.
AU - Lin, H. C.
AU - Yu, C. T.
AU - Kuo, H. P.
PY - 1998
Y1 - 1998
N2 - Monocyte-macrophage series have an important role in host surveillance against cancer. The cytotoxic/cytostatic activity of macrophages is, to a great extent, attributed to the up-regulation of inducible nitric oxide synthase (iNOS) and production of nitric oxide (NO). Here, in 28 patients with primary lung cancer and 20 control subjects, we measured the concentration of exhaled NO and nitrite in epithelial lining fluid (ELF) using a chemiluminescence NO analyser and studied NOS expression in alveolar macrophages (AM) and lung tissues by flow cytometry; immunohistochemical analysis was also undertaken. The mean fluorescence intensity (FI) of iNOS expression in AM was significantly increased in patients with lung cancer (tumour side 263.5 ± 15.2 FI, normal side 232.4 ± 18.6 FI, n = 28) compared with that in control subjects (27.3 ± 3.2 FI; n = 20, P < 0.001). The level of exhaled NO from cancer patients (16.9 ± 0.9 p.p.b.; n = 28) was significantly higher than that in the control group (6.0 ± 0.5 p.p.b.; n = 20, P < 0.001). The level of nitrite was also significantly higher in ELF from cancer patients (tumour side 271.1 ± 28.9 nM and normal side 257.4 ± 19.6 nM vs control subjects 32.9 ± 4.1 nM; P < 0.001). The intensity of iNOS expression in AM was correlated with the level of exhaled NO (r(s) = 0.73, n = 76, P < 0.001) and the nitrite released in ELF (r(s) = 0.56, n = 76, P < 0.001). The nitrite generation of cultured AM from patients with lung cancer was significantly enhanced compared with that of control subjects after culture for 24 h (tumour side 5.75 ± 0.69 and normal side 5.68 ± 0.58 μM per 106 cells vs control group 38.3 ± 3.6 nM per 106 cells; P < 0.001). The distribution of iNOS was identified in AM, tumour-associated macrophages, endothelium, chondrocytes, airway epithelium of both lungs and malignant cells (adenocarcinoma and alveolar cell carcinoma) of cancer patients. cNOS was labelled in alveolar macrophages, endothelial cells and nerve elements from lung tissue. Our results indicate that, in patients with primary lung cancer, the production of NO from alveolar macrophages was increased as a result of the up-regulation of iNOS activity. The increased NO production was not specific to the tumour side and might be attributed to the tumour-associated non-specific immunological and inflammatory processes of the host.
AB - Monocyte-macrophage series have an important role in host surveillance against cancer. The cytotoxic/cytostatic activity of macrophages is, to a great extent, attributed to the up-regulation of inducible nitric oxide synthase (iNOS) and production of nitric oxide (NO). Here, in 28 patients with primary lung cancer and 20 control subjects, we measured the concentration of exhaled NO and nitrite in epithelial lining fluid (ELF) using a chemiluminescence NO analyser and studied NOS expression in alveolar macrophages (AM) and lung tissues by flow cytometry; immunohistochemical analysis was also undertaken. The mean fluorescence intensity (FI) of iNOS expression in AM was significantly increased in patients with lung cancer (tumour side 263.5 ± 15.2 FI, normal side 232.4 ± 18.6 FI, n = 28) compared with that in control subjects (27.3 ± 3.2 FI; n = 20, P < 0.001). The level of exhaled NO from cancer patients (16.9 ± 0.9 p.p.b.; n = 28) was significantly higher than that in the control group (6.0 ± 0.5 p.p.b.; n = 20, P < 0.001). The level of nitrite was also significantly higher in ELF from cancer patients (tumour side 271.1 ± 28.9 nM and normal side 257.4 ± 19.6 nM vs control subjects 32.9 ± 4.1 nM; P < 0.001). The intensity of iNOS expression in AM was correlated with the level of exhaled NO (r(s) = 0.73, n = 76, P < 0.001) and the nitrite released in ELF (r(s) = 0.56, n = 76, P < 0.001). The nitrite generation of cultured AM from patients with lung cancer was significantly enhanced compared with that of control subjects after culture for 24 h (tumour side 5.75 ± 0.69 and normal side 5.68 ± 0.58 μM per 106 cells vs control group 38.3 ± 3.6 nM per 106 cells; P < 0.001). The distribution of iNOS was identified in AM, tumour-associated macrophages, endothelium, chondrocytes, airway epithelium of both lungs and malignant cells (adenocarcinoma and alveolar cell carcinoma) of cancer patients. cNOS was labelled in alveolar macrophages, endothelial cells and nerve elements from lung tissue. Our results indicate that, in patients with primary lung cancer, the production of NO from alveolar macrophages was increased as a result of the up-regulation of iNOS activity. The increased NO production was not specific to the tumour side and might be attributed to the tumour-associated non-specific immunological and inflammatory processes of the host.
KW - Alveolar macrophage
KW - Cytotoxicity
KW - Lung cancer
KW - Nitric oxide
KW - Nitric oxide synthase
KW - Nitrite
UR - http://www.scopus.com/inward/record.url?scp=0031827486&partnerID=8YFLogxK
U2 - 10.1038/bjc.1998.528
DO - 10.1038/bjc.1998.528
M3 - 文章
C2 - 9716040
AN - SCOPUS:0031827486
SN - 0007-0920
VL - 78
SP - 534
EP - 541
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 4
ER -
